Proteomic analysis indicates the importance of TPM3 in esophageal squamous cell carcinoma invasion and metastasis

Yu,Shao-Bin; Gao,Qin; Lin,Wen-Wei; Kang,Ming-Qiang

doi:10.3892/mmr.2017.6145

Proteomic analysis indicates the importance of TPM3 in esophageal squamous cell carcinoma invasion and metastasis

Authors:
- Shao-Bin Yu
- Qin Gao
- Wen-Wei Lin
- Ming-Qiang Kang
View Affiliations

Affiliations: Second Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, P.R. China, Department of General Surgery, Fuzhou General Hospital of Nanjing Military Area Command, Fuzhou, Fujian 350025, P.R. China
Published online on: January 25, 2017 https://doi.org/10.3892/mmr.2017.6145
Pages: 1236-1242
Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Numerous esophageal squamous cell carcinoma (ESCC) patients exhibit tumor recurrence following radical resection. Invasion and metastasis are key factors in poor prognosis following esophagectomy. In the present study, two‑dimensional gel electrophoresis (2-DE) and matrix‑assisted laser desorption/ionization time-of-flight mass spectrometry were used to define patterns of protein expression in ESCC tissues at different pathological stages. The expression levels of identified proteins were determined by immunohistochemistry and western blotting. A total of fifteen protein spots with >2-fold differences were observed when comparing results of 2-DE for stage III and stage I ESCC tissue sample. A total of 12 proteins were identified by mass spectrometry analysis and database searches. The results of immunohistochemistry and western blotting demonstrated expression levels of tropomyosin 3 (TPM3) were higher in stage III ESCC tissue compared with stage I (P<0.05). The findings of the present study identified twelve proteins, which are closely associated with ESCC invasion and metastasis, apoptosis and cell signal transduction. Furthermore, the overexpression of TPM3 may be important in ESCC invasion and metastasis.

View Figures

View References

1	Pennathur A, Gibson MK, Jobe BA and Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013. View Article : Google Scholar : PubMed/NCBI
2	Jia Y, Wang N, Wang J, Tian H, Ma W, Wang K, Tan B, Zhang G, Yang S, Bai B and Cheng Y: Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: A potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis. Ann Surg Oncol. 21:329–336. 2014. View Article : Google Scholar : PubMed/NCBI
3	Wang K, Ma W, Wang J, Yu L, Zhang X, Wang Z, Tan B, Wang N, Bai B, Yang S, et al: Tumor-stroma ratio is an independent predictor for survival in esophageal squamous cell carcinoma. J Thorac Oncol. 7:1457–1461. 2012. View Article : Google Scholar : PubMed/NCBI
4	Zhu YH, Liu H, Zhang LY, Zeng T, Song Y, Qin YR, Li L, Liu L, Li J, Zhang B and Guan XY: Downregulation of LGI1 promotes tumor metastasis in esophageal squamous cell carcinoma. Carcinogenesis. 35:1154–1161. 2014. View Article : Google Scholar : PubMed/NCBI
5	Xuan X, Li Q, Zhang Z, Du Y and Liu P: Increased expression levels of S100A4 associated with hypoxia-induced invasion and metastasis in esophageal squamous cell cancer. Tumour Biol. 35:12535–12543. 2014. View Article : Google Scholar : PubMed/NCBI
6	Hu Y, Correa AM, Hoque A, Guan B, Ye F, Huang J, Swisher SG, Wu TT, Ajani JA and Xu XC: Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int J Cancer. 128:132–143. 2011. View Article : Google Scholar : PubMed/NCBI
7	Kashyap MK, Harsha HC, Renuse S, Pawar H, Sahasrabuddhe NA, Kim MS, Marimuthu A, Keerthikumar S, Muthusamy B, Kandasamy K, et al: SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome. Cancer Biol Ther. 10:796–810. 2010. View Article : Google Scholar : PubMed/NCBI
8	Liu Z, Feng JG, Tuersun A, Liu T, Liu H, Liu Q, Zheng ST, Huang CG, Lv GD, Sheyhidin I and Lu XM: Proteomic identification of differentially-expressed proteins in esophageal cancer in three ethnic groups in Xinjiang. Mol Biol Rep. 38:3261–3269. 2011. View Article : Google Scholar : PubMed/NCBI
9	Zhang J, Wang K, Zhang J, Liu SS, Dai L and Zhang JY: Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma. J Proteome Res. 10:2863–2872. 2011. View Article : Google Scholar : PubMed/NCBI
10	Ying J, Shan L, Li J, Zhong L, Xue L, Zhao H, Li L, Langford C, Guo L, Qiu T, et al: Genome-wide screening for genetic alterations in esophageal cancer by aCGH identifies 11q13 amplification oncogenes associated with nodal metastasis. PLoS one. 7:e397972012. View Article : Google Scholar : PubMed/NCBI
11	Uemura N, Nakanishi Y, Kato H, Saito S, Nagino M, Hirohashi S and Kondo T: Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics. Int J Cancer. 124:2106–2115. 2009. View Article : Google Scholar : PubMed/NCBI
12	Yang Z, Guan B, Men T, Fujimoto J and Xu X: Comparable molecular alterations in 4-nitroquinoline 1-oxide-induced oral and esophageal cancer in mice and in human esophageal cancer, associated with poor prognosis of patients. In vivo. 27:473–484. 2013.PubMed/NCBI
13	Moghanibashi M, Jazii FR, Soheili ZS, Zare M, Karkhane A, Parivar K and Mohamadynejad P: Proteomics of a new esophageal cancer cell line established from Persian patient. Gene. 500:124–133. 2012. View Article : Google Scholar : PubMed/NCBI
14	Fan NJ, Gao CF, Wang CS, Zhao G, Lv JJ, Wang XL, Chu GH, Yin J, Li DH, Chen X, et al: Identification of the up-regulation of TP-alpha, collagen alpha-1(VI) chain and S100A9 in esophageal squamous cell carcinoma by a proteomic method. J Proteomics. 75:3977–3986. 2012. View Article : Google Scholar : PubMed/NCBI
15	da Costa DM, Neves-Filho EH, Alves MK and Rabenhorst SH: Interleukin polymorphisms and differential methylation status in gastric cancer: An association with Helicobacter pylori infection. Epigenomics. 5:167–175. 2013. View Article : Google Scholar : PubMed/NCBI
16	Xue H, Lin B, Ni P, Xu H and Huang G: Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: A meta-analysis. J Gastroenterol Hepatol. 25:1604–1617. 2010. View Article : Google Scholar : PubMed/NCBI
17	Dabrowska M, Skoneczny M and Rode W: Functional gene expression profile underlying methotrexate-induced senescence in human colon cancer cells. Tumor Biol. 32:965–976. 2011. View Article : Google Scholar
18	Su CC, Su JH, Lin JJ, Chen CC, Hwang WI, Huang HH and Wu YJ: An investigation into the cytotoxic effects of 13-acetoxysarcocrassolide from the soft coral Sarcophyton crassocaule on bladder cancer cells. Mar Drugs. 9:2622–2642. 2011. View Article : Google Scholar : PubMed/NCBI
19	Dong P, He XW, Gu J, Wu WG, Li ML, Yang JH, Zhang L, Ding QC, Lu JH, Mu JS, et al: Vimentin significantly promoted gallbladder carcinoma metastasis. Chin Med J (Engl). 124:4236–4244. 2011.PubMed/NCBI
20	Butler MW, Fukui T, Salit J, Shaykhiev R, Mezey JG, Hackett NR and Crystal RG: Modulation of cystatin A expression in human airway epithelium related to genotype, smoking, COPD, and lung cancer. Cancer Res. 71:2572–2581. 2011. View Article : Google Scholar : PubMed/NCBI
21	Lan YJ, Chen H, Chen JQ, Lei QH, Zheng M and Shao ZR: Immunolocalization of vimentin, keratin 17, Ki-67, Involucrin, β-catenin and E-cadherin in cutaneous squamous cell carcinoma. Pathol Oncol Res. 20:263–266. 2014. View Article : Google Scholar : PubMed/NCBI
22	Xia L, Shen C, Fu Y, Tian L and Chen M: MGC29506 induces cell cycle arrest and is downregulated in gastric cancer. Cell Immunol. 281:31–36. 2013. View Article : Google Scholar : PubMed/NCBI
23	Chen JH, Chen LM, Xu LY, Wu MY and Shen ZY: Expression and significance of heat shock proteins in esophageal squamous cell carcinoma. Zhonghua zhong liu za zhi. 28:758–761. 2006.(In Chinese). PubMed/NCBI
24	Choi HS, Yim SH, Xu HD, Jung SH, Shin SH, Hu HJ, Jung CK, Choi JY and Chung YJ: Tropomyosin3 overexpression and a potential link to epithelial-mesenchymal transition in human hepatocellular carcinoma. BMC cancer. 10:1222010. View Article : Google Scholar : PubMed/NCBI
25	Pieples K, Arteaga G, Solaro RJ, Grupp I, Lorenz JN, Boivin GP, Jagatheesan G, Labitzke E, DeTombe PP, Konhilas JP, et al: Tropomyosin 3 expression leads to hypercontractility and attenuates myofilament length-dependent Ca(2+) activation. Am J Physiol Heart Circ Physio. 283:H1344–H1353. 2002. View Article : Google Scholar
26	Greco A, Miranda C and Pierotti MA: Rearrangements of NTRK1 gene in papillary thyroid carcinoma. Mol Cell Endocrinol. 321:44–49. 2010. View Article : Google Scholar : PubMed/NCBI
27	Li Z, Yang R, Zhao J, Yuan R, Lu Q, Li Q and Tse W: Molecular diagnosis and targeted therapy of a pediatric chronic eosinophilic leukemia patient carrying TPM3-PDGFRB fusion. Pediatr Blood Cancer. 56:463–466. 2011. View Article : Google Scholar : PubMed/NCBI